The synchronously change of CYLD phosphorylation and BTK phosphorylation suggested that CYLD phosphorylation should be regulated through inhibition of BTK phosphorylation, which might regulate tumor cell death in non-GCB-DLBCL. The gene discussed is BTK; the disease is neoplasm.